ATORVASTATIN AND RIFAXIMIN IN THYROID PREVENT LIVER THYROID METABOLISM ABNORMALITIES IN HEPATOCELLULAR CARCINOMA: IN VITRO AND IN VIVO STUDY Bruno de Souza Basso; Thaliane Carvalho de Oliveira; Rachel Pinto Dornelles; Daiane Dias Cabeleira; Elisa Carolina Lange; Cristiane Gisele Gomes; Emanuela Tureta Cagnini; Luca Prá Scherer; Henrique Mombach Barreto; Leonardo Priesnitz Friedrich; Gustavo Santos Lucca; Maria Alice Smielevski Gomes; Carolina Fischer Nadvorny; Jessica Sindo; Maria Ines Gonzales Solari; Patricia Bencke Grudzinski; Laura Alvarez; Ezequiel Ridruejo; Simone Macagnin Wajner; Mario Reis Alvares-da-Silva;

DIFFERENT LIPIDOMIC SIGNATURE IN EXTRACELLULAR VESICLES IN PATIENTS WITH MASLD- HCC: ANALYSIS OF DIFFERENT STAGES OF MASLD Mario Reis Alvares-da-Silva; Melina Keingeski Belén; Larisse Longo; Bruno de Souza Basso; Jose Tadeu Stefano; Claudia Pinto Oliveira; Carolina Uribe-Cruz; Juan Pablo Arab Verdugo;

GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA Cassio Marques Perlin; Melina Keingeski Belén; Bruno de Souza Basso; Beatriz Mendes Borba; Julliane Dutra Medeiros; Francis Moreira Borges; Bernd Schnabl; Mario Reis Alvares-da-Silva;